Rapid development of pluripotent stem cells as a potential therapeutic modality

Molecular Therapy

Volumn 17, Issue 6, 2009, Pages 929-930

  Williams, David A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

CHIMERA; EDITORIAL; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; SOMATIC CELL; TISSUE TRANSPLANTATION; TRANSPOSON;

EID: 66749113976     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.97     Document Type: Editorial

References (4)

1. Müller, LUW, Daley, GQ and Williams, DA (2009). Upping the ante: recent advances in direct reprogramming. Mol Ther 17: 947-953.
2. Kaji, K, Norrby, K, Paca, A, Mileikovsky, M, Mohseni, P and Woltjen, K (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775.
3. Soldner, F, Hockemeyer, D, Beard, C, Gao, Q, Bell, GW, Cook, EG et al. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964-977.
4. Yu, J, Hu, K, Smuga-Otto, K, Tian, S, Stewart, R, Slukvin, II et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science; e-pub ahead of print, 26 March 2009.